Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 12 Similar Profiles
irinotecan Medicine & Life Sciences
Pharmacogenetics Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Glucuronosyltransferase Medicine & Life Sciences
Pharmacokinetics Medicine & Life Sciences
Genotype Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1992 2020

Research Output 1994 2018

A transnational collaborative network dedicated to the study and applications of the vascular endothelial growth factor-A in medical practice: The VEGF Consortium

Stathopoulou, M. G. , Xie, T. , Ruggiero, D. , Chatelin, J. , Rancier, M. , Weryha, G. , Kurth, M. J. , Aldasoro Arguinano, A. A. , Gorenjak, V. , Petrelis, A. M. , Dagher, G. , Dedoussis, G. , Deloukas, P. , Lamont, J. , Marc, J. , Simmaco, M. , Van Schaik, R. H. N. , Innocenti, F. , Merlin, J. L. , Schneider, J. & 4 others Alizadeh, B. Z., Ciullo, M., Seshadri, S. & Visvikis-Siest, S. Mar 28 2018 In : Clinical Chemistry and Laboratory Medicine. 56, 4, p. e83-e86

Research output: Contribution to journalLetter

Precision Medicine
Vascular Endothelial Growth Factor A

“No pain, No gain” still true with immunotherapy: When the finger shows the moon, look at the moon!

Milano, G., Innocenti, F., Lacarelle, B. & Ciccolini, J. Jul 1 2018 In : Critical Reviews in Oncology/Hematology. 127, p. 1-5 5 p.

Research output: Contribution to journalReview article

Immunotherapy
Fingers
Therapeutics
Precision Medicine
Drug-Related Side Effects and Adverse Reactions

8th Santorini Conference: Systems medicine and personalized health and therapy, Santorini, Greece, 3-5 October 2016

Visvikis-Siest, S. , Aldasoro Arguinano, A. A. , Stathopoulou, M. , Xie, T. , Petrelis, A. , Weryha, G. , Froguel, P. , Meier-Abt, P. , Meyer, U. A. , Mlakar, V. , Ansari, M. , Papassotiropoulos, A. , Dedoussis, G. , Pan, B. , Bühlmann, R. P. , Noyer-Weidner, M. , Dietrich, P. Y. , Van Schaik, R. , Innocenti, F. , März, W. & 2 others Bekris, L. M. & Deloukas, P. Jun 1 2017 In : Drug Metabolism and Personalized Therapy. 32, 2, p. 119-127 9 p.

Research output: Contribution to journalArticle

1 Citations

Bringing a genomic perspective to the safety of drug treatment in oncology

Innocenti, F. 2017 In : F1000Research. 6, 385

Research output: Contribution to journalReview article

Drug therapy
Oncology
Safety
Toxicity
Pharmaceutical Preparations
3 Citations

Cost Evaluation of Irinotecan-Related Toxicities Associated With the UGT1A1*28 Patient Genotype

Roncato, R., Cecchin, E., Montico, M., De Mattia, E., Giodini, L., Buonadonna, A., Solfrini, V., Innocenti, F. & Toffoli, G. Jul 1 2017 In : Clinical pharmacology and therapeutics. 102, 1, p. 123-130 8 p.

Research output: Contribution to journalArticle

irinotecan
Genotype
Costs and Cost Analysis
Confidence Intervals
Standard of Care